Galal, Salma Tarek Rafik AbdELKhalek;
(2025)
Pharmacological and therapeutic studies using a bioengineered 3D breast cancer model.
Doctoral thesis (Ph.D), UCL (University College London).
![]() |
Text
Galal_10212575_Thesis.pdf Access restricted to UCL open access staff until 1 March 2027. Download (47MB) |
Abstract
The breast tumour microenvironment comprises specific biophysical, biochemical, and cellular facets, which include a collagen-rich extracellular matrix and a mixture of tumour cells and stromal cells. The interactions between tumour cells and their microenvironment alter tumour behaviour and impact response to therapies. Despite their common use in breast cancer studies, in vitro 2D cell cultures exhibit limited biomimicry of breast cancer complexity. 3D cell culture models are more biomimetic as they recapitulate the physiological 3D tissue architecture of the tumour microenvironment. In this study, a biomimetic 3D in vitro breast tumour model, termed ‘tumouroid’, was developed by incorporating breast tumour cells within a complex stroma to mimic the physiological tumour microenvironment. This model was used to investigate the therapeutic effects of targeted nano-delivery systems, combined ultrasound with chemotherapy and photodynamic therapy in the treatment of breast cancer. A novel 3D multi-compartment dense collagen I gel was engineered, where either MCF-7 or MDA-MB-231 breast cancer cells were embedded within a central artificial tumour mass surrounded by a stromal compartment composed of stromal cells with various extracellular matrix proteins. The impact of the stromal compartment on cancer cell growth and invasion, along with changes in oxygen levels, was evaluated in 3D tumouroids. The response to different therapies, including doxorubicin, liposomal doxorubicin, hyaluronic nanoparticles encapsulating doxorubicin, and photoactivatable drugs, was assessed in 3D tumouroids via imaging, cell viability assay, and real-time monitoring of oxygen gradient levels. Finally, the effect of ultrasound application on the uptake of previously drug-treated tumouroids was investigated. 3D breast tumouroids were successfully established where the presence of adipose tissue-derived mesenchymal stem cells and extracellular matrix proteins in the stromal compartment influenced vascular network formation, hypoxia development, cancer cell growth, invasion, as well as response to therapies. The stromal compartment significantly enhanced the tumourigenic potential of the less metastatic MCF-7 breast cancer cells compared to the highly metastatic MDA-MB-231. Direct killing of tumour cells was observed in addition to disruption of vascular networks and alleviation of hypoxia, in response to doxorubicin, hyaluronic nanoparticles encapsulating doxorubicin, and combined doxorubicin/photoactivatable drug treatments. MCF-7 breast cancer cells showed higher drug therapeutic responses compared to MDA-MB-231 breast cancer cells. Ultrasound application improved the cell-killing effects of doxorubicin and liposomal doxorubicin in MDA-MB-231 3D tumouroids. In conclusion, 3D breast tumouroids display biomimicry of the in vivo breast tumour microenvironment and the ability to distinguish between different drug responses, which support their suitability as a platform for mechanistic studies of tumour biology and therapeutic screening.
Type: | Thesis (Doctoral) |
---|---|
Qualification: | Ph.D |
Title: | Pharmacological and therapeutic studies using a bioengineered 3D breast cancer model |
Language: | English |
Additional information: | Copyright © The Author 2025. Original content in this thesis is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) Licence (https://creativecommons.org/licenses/by-nc/4.0/). Any third-party copyright material present remains the property of its respective owner(s) and is licensed under its existing terms. Access may initially be restricted at the author’s request. |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Surgery and Interventional Sci UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Surgery and Interventional Sci > Department of Targeted Intervention |
URI: | https://discovery.ucl.ac.uk/id/eprint/10212575 |
Archive Staff Only
![]() |
View Item |